BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 4247823)

  • 1. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    Thomas DP; Niewiarowski S; Myers AR; Bloch KJ; Colman RW
    N Engl J Med; 1970 Sep; 283(13):663-8. PubMed ID: 4247823
    [No Abstract]   [Full Text] [Related]  

  • 2. [Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
    Thuot C; Perron L
    Union Med Can; 1973 Jan; 102(1):66-9. PubMed ID: 4706340
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperfibrinolysis in cirrhosis.
    Pises P; Bick R; Siegel B
    Am J Gastroenterol; 1973 Sep; 60(3):280-9. PubMed ID: 4126798
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical significance of fibrinogen degradation products.
    Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
    J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of hypercoagulable states with protamine sulphate tests.
    Lipinski B
    Acta Univ Carol Med Monogr; 1972; 52():185-8. PubMed ID: 4273929
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravascular coagulation-fibrinolysis (ICF) syndrome.
    Owen CA; Bowie EJ
    Ann Clin Lab Sci (1971); 1972; 2(1):26-30. PubMed ID: 4263611
    [No Abstract]   [Full Text] [Related]  

  • 8. [Natural inhibitors of fibrinolysis and thrombohemorrhagic phenomena].
    Moriau M
    Pathol Eur; 1969; 4():Suppl 1:9-286. PubMed ID: 4244510
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinolytic activity of the blood and synovial fluid in patients with rheumatoid arthritis].
    Erov NK
    Ter Arkh; 1986; 58(7):73-7. PubMed ID: 2945279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihaemophilic factor A (F VIII) and serum fibrin-fibrinogen degradation products in hepatic cirrhosis.
    van Outryve M; Baele G; de Weerdt GA; Barbier F
    Scand J Haematol; 1973; 11(2):148-52. PubMed ID: 4773962
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
    Matsuda T
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):628-36. PubMed ID: 4677378
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlation between fibrinolysis and the indexes of blood coagulation and of hepatic damage in chronic liver disease and liver cirrhosis].
    Craveri A; Cerrini R; Repaci G; Saracino F
    G Clin Med; 1968 Dec; 49(12):1326-53. PubMed ID: 4242987
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of fibrinogen degradation products.
    Cohen RJ
    N Engl J Med; 1970 Dec; 283(26):1465-6. PubMed ID: 5481782
    [No Abstract]   [Full Text] [Related]  

  • 14. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 15. On fibrinolysis and coagulation during parturition and menstruation.
    Hahn L
    Acta Obstet Gynecol Scand Suppl; 1974; 28():7-40. PubMed ID: 4599650
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulation assays in detecting thrombosis-prone patients on oral contraceptives.
    Genton E
    Milbank Mem Fund Q; 1972 Jan; 50(1):Suppl 2:24-30. PubMed ID: 5030462
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifibrinolytics gynaecology and obstetrics.
    Koutský J; Hladovec J
    Acta Univ Carol Med (Praha); 1975; 21(5-6):235-386. PubMed ID: 132853
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].
    Enev N
    Vutr Boles; 1978; 17(3):41-5. PubMed ID: 150133
    [No Abstract]   [Full Text] [Related]  

  • 19. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
    Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
    Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential diagnosis between primary and secondary hyperfibrinolysis].
    Heene DL
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):186-94. PubMed ID: 4098772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.